Published in:
01-09-2021 | Magnetic Resonance Cholangio Pancreatography | Surgery in Low and Middle Income Countries
Management of Obscurely Dilated Common Bile Duct with Normal Liver Function Tests: A Pragmatic Approach
Published in: World Journal of Surgery | Issue 9/2021
Login to get accessAbstract
Objective
Dilated common bile duct (CBD) (8–15 mm) with normal liver function tests is seen not infrequently, while management of such patients is ambiguous. We propose a treatment algorithm for this cohort of patients after observing them over a period of 8 years.
Methods
Seventy-eight such patients were managed from 2009 to 2017 and categorized as: Group A—dilated CBD with post-cholecystectomy status (n = 15); B—dilated CBD with cholelithiasis (n = 34); C—dilated CBD without cholelithiasis (n = 16); D—dilated CBD with no cause identified and underwent CBD excision (n = 13). Causes for CBD dilatation were evaluated. The outcome of patients in Group B + C without any cause (n = 33) was compared with Group D.
Result
Median age, CBD diameter, bilirubin and alkaline phosphatase were 51 years (13–79), 10 mm (8–20), 0.6 mg/dl (0.2–2.5) and 126 IU (60–214), respectively. Group-A patients who did not manifest any cause of CBD dilatation were managed conservatively. The aetiology was identified in 17/50 patients in Group B & C [acute pancreatitis (n = 6), passed CBD calculi (n = 3), perivaterian diverticulum (n = 3), viral aetiology (n = 4) and tumour (n-1)]. In Group-C, 7 patients with no obvious cause underwent endoscopic sphincterotomy, pancreatoduodenectomy (n = 1), and the rest were managed conservatively (n = 8). There was no significant difference in the complication between Group B + C (without any cause) and Group D (3/33 vs. 1/13; p = 0.58) at a median follow-up of 72 months (30–90).
Conclusion
Dilated CBD with normal LFT’s without apparent cause is mostly benign and of no consequence. Excision of the CBD is not required for most of these patients.